A Phase III, Randomized, Multicenter, Double-Blind, Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 27 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

28 Oct 2020 Results (n=582) of a sub-group analysis assessing effects of IV iron treatment on incidence of hypophosphatemia in subgroup of patients with Iron deficiency anemia caused by a variety of upper and lower GI disorders presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2020
06 Nov 2019 Results (n=153) of post hoc analyses from subgroup of cancer patients, released in 61st Annual Meeting and Exposition of the American Society of Hematology
21 Dec 2018 Puerto Rico was a planned location.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com